The compounds
[Mn2(bpm)3(NCS)4]
(1), [Mn(bpm)(NCO)2] (2),
and [Mn2(bpm)(N3)4]
(3) (where bpm= 2,2‘-bipyrimidine) have been synthesized and characterized. Compound
1 crystallizes in the triclinic P1̄ space
group,
with a = 9.122(1) Å, b = 9.229(1)
Å, c = 11.710(2) Å, α = 74.89(1)°, β
= 80.30(1)°, γ = 61.04(1)°, V
=
831.7(2) Å3, Z = 2,
R(F
o) = 0.029, and
wR(F
o
2) = 0.078.
Compound 2 crystallizes in the monoclinic
C2/c space
group, with a = 7.309(1) Å, b =
14.498(2) Å, c = 10.740(4) Å, β =
99.93(4)°, V = 1121.0(5) Å3,
Z = 4, R =
0.025, and wR(F
o
2) =
0.060. In the case of compound 3, the crystal
parameters of the monoclinic C2/m
space
group are a = 6.206(2) Å, b =
15.084(2) Å, c = 8.909(1) Å, β =
95.75(2)°, V = 829.8(3) Å3,
Z = 4, R = 0.029,
and wR(F
o
2)= 0.069.
The pseudohalide ions have a dramatic influence in the molecular
structures of the three
compounds. Compound 1 is dinuclear, with the
manganese(II) ions bridged by bpm ligands and with
terminal
bpm and NCS groups; compound 2 is a linear chain of
manganese(II) ions bridged by bpm ligands in
cis
conformation, with terminal cyanate groups; compound 3 shows
a two-dimensional honeycomb like structure,
where the sheets consist of an infinite hexagonal array of
manganese(II) ions bridged by bischelating bpm
ligands
and double end-on azido bridges. The manganese(II) ions have
octahedral environments in all cases. Magnetic
susceptibility measurements show antiferromagnetic couplings for
compounds 1 and 2, while alternating
ferro-antiferromagnetism is observed for compound 3. The
obtained exchange parameters are J = −0.72 K and
J =
−0.78 K for compounds 1 and 2, respectively.
No theoretical model is available for compound 3, which
represent
the first two-dimensional honeycomb-like compound showing alternating
signs in the magnetic interactions.